Arcadia Biosciences, Inc. Annual Operating Income (Loss) in USD from 2014 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Arcadia Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2024.
  • Arcadia Biosciences, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$804K, a 231% decline year-over-year.
  • Arcadia Biosciences, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$3.65M, a 40.2% increase year-over-year.
  • Arcadia Biosciences, Inc. annual Operating Income (Loss) for 2024 was -$3.65M, a 40.2% increase from 2023.
  • Arcadia Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$6.1M, a 56.4% increase from 2022.
  • Arcadia Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$14M, a 60.6% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$3.65M +$2.45M +40.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-25
2023 -$6.1M +$7.91M +56.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-25
2022 -$14M +$21.5M +60.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$35.5M -$22.7M -178% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$12.8M +$6.6M +34.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$19.4M -$2.51M -14.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$16.9M -$2.56M -17.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-25
2017 -$14.3M +$4.31M +23.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$18.6M -$3.06M -19.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-20
2015 -$15.6M -$410K -2.71% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-08
2014 -$15.2M Jan 1, 2014 Dec 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.